Kalderos today announced the appointment of Brent Dover as CEO. He succeeds company founder Jeremy Docken, who will remain on the board and who's new title is chief strategy officer.

Kalderos Hires Veteran Health Care Tech Company Leader Brent Dover to be its New CEO

In Pharma IndustryFebruary 3, 2022282 Views

Tom Mirga

Drug industry technology company Kalderos, which has struggled to launch its 340B Pay service to let drug companies provide 340B pricing as a post-purchase rebate instead of as an up-front discount, has replaced its chief executive officer.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Exact matches only

Search in title

Search in content

Search in excerpt

Hidden

*Sign up for news summaries and alerts from 340B Report